app

Urology

News, opinions and meeting coverage in urology.

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

— Health news and commentary gathered by app staff

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Latest in Urology

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

New treatments reshape metastatic and muscle-invasive bladder cancer therapy

Nov 22, 2024
Texas Has Sued Three Doctors Over Youth Gender-Affirming Care

All three physicians could lose their licenses

Nov 20, 2024
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with complete response can have long treatment-free interval, study suggests

Nov 15, 2024
Targeted Combination Shows Promise in Metastatic Kidney Cancer

Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC

Nov 13, 2024
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with complete response can have long treatment-free interval, study suggests

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC

More in Urology

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

Possible guidance for use of adjuvant immunotherapy in high-risk, non-metastatic disease

Nov 12, 2024
IKCS over a photo of Omni Louisville in Louisville, KY.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

Better OS, PFS, response rate, but newer combination strategies not included

Nov 12, 2024
IKCS over a photo of Omni Louisville in Louisville, KY.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

VA analysis finds men with limited life expectancy still getting aggressive treatment

Nov 11, 2024
 A photo of a man being helped by a female healthcare worker following radiotherapy for prostate cancer.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

More IKCS news: Long-term survival benefit with nivolumab/ipilimumab, disease-slowing surgery

Nov 11, 2024
IKCS over a photo of Omni Louisville in Louisville, KY.
Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

Low rate of recurrence with surgery or nonsurgical options, but data can inform decisions

Nov 10, 2024
IKCS over a photo of Omni Louisville in Louisville, KY.
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

Confirmed responses in one-fourth to one-third of patients with refractory disease

Nov 09, 2024
IKCS over a photo of Omni Louisville in Louisville, KY.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

Nov 08, 2024
image
Prostate Cancer Treatment Associated With Long-Term Complications

Researchers say inadequate understanding of risks may lead patients to regret treatment decisions

Nov 07, 2024
A photo of radiologists preparing a linear accelerator.
How Trump's Win Affects Healthcare; Uptick in COVID; Pesticides and Prostate Cancer

Health news and commentary gathered by app staff

Nov 06, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
Cranberry, Antibiotic May Help Kids With Recurrent UTI

Meta-analysis finds one most effective option to prevent symptomatic episodes

Nov 04, 2024
A photo of a little boy drinking cranberry juice through a striped straw.
Pediatric Febrile UTI May Hurt Kidney Function

Study also raises question of antibiotic prophylaxis in kids with common congenital anomaly

Oct 26, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
FDA Approves Novel Treatment for UTIs

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Oct 25, 2024
FDA APPROVED sulopenem etzadroxil and probenecid (Orlynvah) over a computer rendering of a urinary tract infection.
Few Teens Regret Gender-Affirming Medical Care, Survey Shows

Only 4% reported regret after receiving puberty blockers, gender-affirming hormones

Oct 21, 2024
A computer rendering of a pill with the transgender symbol stamped into it.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval

In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy

Oct 18, 2024
A photo of the packaging and vial of Trodelvy.
More in Urology

Latest Meetings